Skip to main content

Market Overview

What's Happening With CRIS Stock, SRGA Stock And PDD Stock Wednesday?

Share:
What's Happening With CRIS Stock, SRGA Stock And PDD Stock Wednesday?

One of the most common questions traders have about stocks is “Why Is It Moving?”

That’s why Benzinga created the Why Is It Moving, or WIIM, feature in Benzinga Pro

WIIMs are a one-sentence description as to why that stock is moving.

Here’s the latest news and updates for Curis, Surgalign and Pinduoduo.

Curis, Inc. (NASDAQ: CRIS) shares are trading lower after the company reported worse-than-expected fourth-quarter EPS results.

Curis is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas

Surgalign Holdings Inc (NASDAQ: SRGA) shares are trading lower after the company reported worse-than-expected fourth-quarter EPS results.

Surgalign is a medical technology company advancing the science of spine care, focused on delivering innovative solutions that drive superior clinical and economic outcomes. 

Pinduoduo Inc - ADR (NASDAQ: PDD) shares are trading lower after the company reported worse-than-expected fourth-quarter EPS results.

Pinduoduo also announced that its founder, Colin Huang, has stepped down from the board of directors effective today to pursue research in the food and life sciences. Pinduoduo provides a platform for buyers with value-for-money merchandise and fun and interactive shopping experiences. 

 

Related Articles (PDD + CRIS)

View Comments and Join the Discussion!

Posted-In: Earnings News Penny Stocks Small Cap

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com